智通财经APP讯,华昊中天医药-B(02563)发布公告,本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元,而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。
董事会认为,上述亏损减少主要得益于产品市场渗透提高导致销售收入增长、产品生产工艺优化所带来的销售成本降低以及严格控制销售开支所带来的销售费用减少。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.